CompletedNot applicableNCT01051076

Rescue Immunotolerance Study in Induction of Immune Tolerance (ITI)-Experienced Patients (RES.I.S.T. Experienced)

Studying Hemophilia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
City of Hope Medical Center
Principal Investigator
Nadia P. Ewing, MD
Clinical Professor of Pediatrics, City of Hope National Medical Center, Dept. of Pediatrics, 1500 E. Duarte Rd. Duarte, CA 91010
Intervention
VWF/FVIII concentrates(drug)
Enrollment
3 enrolled
Eligibility
MALE
Timeline
2009 – 2020

Study locations (1)

Collaborators

Charta Foundation · Grifols Biologicals, LLC · CSL Behring · Biotest Pharmaceuticals Corporation · Grifols Therapeutics LLC

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01051076 on ClinicalTrials.gov

Other trials for Hemophilia

Additional recruiting or active studies for the same condition.

See all trials for Hemophilia →

← Back to all trials